{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:01:26Z","timestamp":1794279686573,"version":"4.9.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7727","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41586-018-0603-3","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T16:29:42Z","timestamp":1538756982000},"page":"434-438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy"],"prefix":"10.1038","volume":"562","author":[{"given":"Adriana","family":"S\u00e1nchez-Dan\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Larsimont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Liagre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Mu\u00f1oz-Couselo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Lapouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Brisebarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Suppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayakumar","family":"Sukumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"del Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Tabernero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Blanpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"603_CR1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrc2503","volume":"8","author":"EH Epstein","year":"2008","unstructured":"Epstein, E. H. Basal cell carcinomas: attack of the hedgehog. Nat. Rev. Cancer 8, 743\u2013754 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"603_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1158\/1535-7163.MCT-14-0703","volume":"14","author":"N Basset-Seguin","year":"2015","unstructured":"Basset-Seguin, N., Sharpe, H. J. & de Sauvage, F. J. Efficacy of Hedgehog pathway inhibitors in basal cell carcinoma. Mol. Cancer Ther. 14, 633\u2013641 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"603_CR3","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","volume":"366","author":"A Sekulic","year":"2012","unstructured":"Sekulic, A. et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N. Engl. J. Med. 366, 2171\u20132179 (2012).","journal-title":"N. Engl. J. Med."},{"key":"603_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1172\/JCI58779","volume":"122","author":"M Kasper","year":"2012","unstructured":"Kasper, M., Jaks, V., Hohl, D. & Toftg\u00e5rd, R. Basal cell carcinoma - molecular biology and potential new therapies. J. Clin. Invest. 122, 455\u2013463 (2012).","journal-title":"J. Clin. Invest."},{"key":"603_CR5","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/S1470-2045(16)30566-6","volume":"17","author":"JY Tang","year":"2016","unstructured":"Tang, J. Y. et al. Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 17, 1720\u20131731 (2016).","journal-title":"Lancet Oncol."},{"key":"603_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","volume":"27","author":"SX Atwood","year":"2015","unstructured":"Atwood, S. X. et al. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell 27, 342\u2013353 (2015).","journal-title":"Cancer Cell"},{"key":"603_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","volume":"27","author":"HJ Sharpe","year":"2015","unstructured":"Sharpe, H. J. et al. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. Cancer Cell 27, 327\u2013341 (2015).","journal-title":"Cancer Cell"},{"key":"603_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ncb2031","volume":"12","author":"KK Youssef","year":"2010","unstructured":"Youssef, K. K. et al. Identification of the cell lineage at the origin of basal cell carcinoma. Nat. Cell Biol. 12, 299\u2013305 (2010).","journal-title":"Nat. Cell Biol."},{"key":"603_CR9","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ncb2628","volume":"14","author":"KK Youssef","year":"2012","unstructured":"Youssef, K. K. et al. Adult interfollicular tumour-initiating cells are reprogrammed into an embryonic hair follicle progenitor-like fate during basal cell carcinoma initiation. Nat. Cell Biol. 14, 1282\u20131294 (2012).","journal-title":"Nat. Cell Biol."},{"key":"603_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.stem.2017.10.001","volume":"21","author":"JA Brown","year":"2017","unstructured":"Brown, J. A. et al. TGF-\u03b2-induced quiescence mediates chemoresistance of tumor-propagating cells in squamous cell carcinoma. Cell Stem Cell 21, 650\u2013664.e8 (2017).","journal-title":"Cell Stem Cell"},{"key":"603_CR11","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1242\/dev.083113","volume":"140","author":"N Barker","year":"2013","unstructured":"Barker, N., Tan, S. & Clevers, H. Lgr proteins in epithelial stem cell biology. Development 140, 2484\u20132494 (2013).","journal-title":"Development"},{"key":"603_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature10408","volume":"478","author":"H Tian","year":"2011","unstructured":"Tian, H. et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478, 255\u2013259 (2011).","journal-title":"Nature"},{"key":"603_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.stem.2013.07.010","volume":"13","author":"ME Page","year":"2013","unstructured":"Page, M. E., Lombard, P., Ng, F., G\u00f6ttgens, B. & Jensen, K. B. The epidermis comprises autonomous compartments maintained by distinct stem cell populations. Cell Stem Cell 13, 471\u2013482 (2013).","journal-title":"Cell Stem Cell"},{"key":"603_CR14","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/ng.192","volume":"40","author":"SH Yang","year":"2008","unstructured":"Yang, S. H. et al. Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt\/\u03b23-catenin signaling. Nat. Genet. 40, 1130\u20131135 (2008).","journal-title":"Nat. Genet."},{"key":"603_CR15","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1128004","volume":"312","author":"H Rhee","year":"2006","unstructured":"Rhee, H., Polak, L. & Fuchs, E. Lhx2 maintains stem cell character in hair follicles. Science 312, 1946\u20131949 (2006).","journal-title":"Science"},{"key":"603_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2004.08.012","volume":"118","author":"C Blanpain","year":"2004","unstructured":"Blanpain, C., Lowry, W. E., Geoghegan, A., Polak, L. & Fuchs, E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118, 635\u2013648 (2004).","journal-title":"Cell"},{"key":"603_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2016.10.018","volume":"20","author":"M Latil","year":"2017","unstructured":"Latil, M. et al. Cell-type-specific chromatin states differentially prime squamous cell carcinoma tumor-initiating cells for epithelial to mesenchymal transition. Cell Stem Cell 20, 191\u2013204.e5 (2017).","journal-title":"Cell Stem Cell"},{"key":"603_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature19069","volume":"536","author":"A S\u00e1nchez-Dan\u00e9s","year":"2016","unstructured":"S\u00e1nchez-Dan\u00e9s, A. et al. Defining the clonal dynamics leading to mouse skin tumour initiation. Nature 536, 298\u2013303 (2016).","journal-title":"Nature"},{"key":"603_CR19","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1158\/2159-8290.CD-17-0281","volume":"7","author":"X Zhao","year":"2017","unstructured":"Zhao, X. et al. A transposon screen identifies loss of primary cilia as a mechanism of resistance to SMO inhibitors. Cancer Discov. 7, 1436\u20131449 (2017).","journal-title":"Cancer Discov."},{"key":"603_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nm.4476","volume":"24","author":"RJ Whitson","year":"2018","unstructured":"Whitson, R. J. et al. Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nat. Med. 24, 271\u2013281 (2018).","journal-title":"Nat. Med."},{"key":"603_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccell.2017.12.015","volume":"33","author":"M Eberl","year":"2018","unstructured":"Eberl, M. et al. Tumor architecture and notch signaling modulate drug response in basal cell carcinoma. Cancer Cell 33, 229\u2013243.e4 (2018).","journal-title":"Cancer Cell"},{"key":"603_CR22","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ncb3535","volume":"19","author":"JD Hoeck","year":"2017","unstructured":"Hoeck, J. D. et al. Stem cell plasticity enables hair regeneration following Lgr5+ cell loss. Nat. Cell Biol. 19, 666\u2013676 (2017).","journal-title":"Nat. Cell Biol."},{"key":"603_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature21713","volume":"543","author":"F Sousa e Melo de","year":"2017","unstructured":"de Sousa e Melo, F. et al. A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature 543, 676\u2013680 (2017).","journal-title":"Nature"},{"key":"603_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature22081","volume":"545","author":"M Shimokawa","year":"2017","unstructured":"Shimokawa, M. et al. Visualization and targeting of LGR5+ human colon cancer stem cells. Nature 545, 187\u2013192 (2017).","journal-title":"Nature"},{"key":"603_CR25","doi-asserted-by":"publisher","first-page":"20224","DOI":"10.1073\/pnas.1314239110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc. Natl Acad. Sci. USA 110, 20224\u201320229 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"603_CR26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nrc3410","volume":"12","author":"PA Northcott","year":"2012","unstructured":"Northcott, P. A. et al. Medulloblastomics: the end of the beginning. Nat. Rev. Cancer 12, 818\u2013834 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"603_CR27","doi-asserted-by":"publisher","first-page":"8551","DOI":"10.1073\/pnas.96.15.8551","volume":"96","author":"V Vasioukhin","year":"1999","unstructured":"Vasioukhin, V., Degenstein, L., Wise, B. & Fuchs, E. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc. Natl Acad. Sci. USA 96, 8551\u20138556 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"603_CR28","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1182\/blood-2007-02-075648","volume":"110","author":"A Uhmann","year":"2007","unstructured":"Uhmann, A. et al. The Hedgehog receptor Patched controls lymphoid lineage commitment. Blood 110, 1814\u20131823 (2007).","journal-title":"Blood"},{"key":"603_CR29","doi-asserted-by":"publisher","first-page":"10171","DOI":"10.1158\/0008-5472.CAN-06-0657","volume":"66","author":"J Mao","year":"2006","unstructured":"Mao, J. et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res. 66, 10171\u201310178 (2006).","journal-title":"Cancer Res."},{"key":"603_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/ng747","volume":"29","author":"J Jonkers","year":"2001","unstructured":"Jonkers, J. et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29, 418\u2013425 (2001).","journal-title":"Nat. Genet."},{"key":"603_CR31","first-page":"2753","volume":"45","author":"CM Aldaz","year":"1985","unstructured":"Aldaz, C. M., Conti, C. J., Gimenez, I. B., Slaga, T. J. & Klein-Szanto, A. J. Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Cancer Res. 45, 2753\u20132759 (1985).","journal-title":"Cancer Res."},{"key":"603_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ydbio.2008.08.034","volume":"324","author":"CA Collins","year":"2008","unstructured":"Collins, C. A. & Watt, F. M. Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for \u03b2-catenin and Notch signalling. Dev. Biol. 324, 55\u201367 (2008).","journal-title":"Dev. Biol."},{"key":"603_CR33","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1242\/dev.00703","volume":"130","author":"KM Braun","year":"2003","unstructured":"Braun, K. M. et al. Manipulation of stem cell proliferation and lineage commitment: visualisation of label-retaining cells in wholemounts of mouse epidermis. Development 130, 5241\u20135255 (2003).","journal-title":"Development"},{"key":"603_CR34","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nprot.2010.39","volume":"5","author":"KB Jensen","year":"2010","unstructured":"Jensen, K. B., Driskell, R. R. & Watt, F. M. Assaying proliferation and differentiation capacity of stem cells using disaggregated adult mouse epidermis. Nat. Protoc. 5, 898\u2013911 (2010).","journal-title":"Nat. Protocols"},{"key":"603_CR35","doi-asserted-by":"publisher","first-page":"e14418","DOI":"10.1371\/journal.pone.0014418","volume":"5","author":"E Gonzalez-Roca","year":"2010","unstructured":"Gonzalez-Roca, E. et al. Accurate expression profiling of very small cell populations. PLoS One 5, e14418 (2010).","journal-title":"PLoS One"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-018-0603-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-018-0603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-018-0603-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:50:17Z","timestamp":1684619417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-018-0603-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":35,"journal-issue":{"issue":"7727","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1038\/s41586-018-0603-3","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"3 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.B. is a consultant at Genentech (San Francisco, USA).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}